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Introduction
Aims and Objectives
Comparison of dried blood-to-plasma equivalency values (PEV) 
against plasma concentration
Conclusions
 To describe the use of Mitra® volumetric absorptive microsampler (VAMS) (Torrance, CA,
USA) for LC-MS/MS measurement of 25OHD3 and interpretation of vitamin D status.
 To compare assay performance of Mitra VAMS against paper-based dried blood spot
techniques.
Method of analysis
Use of dried blood-to-plasma equivalency value for interpretation 
of vitamin D status
 Since the introduction of Guthrie cards in the 70s, filter paper method for collection of dried blood spots (DBS) has gained popularity as an alternative form of sampling technique to venepuncture.
 DBS sampling is less invasive than venepuncture; whilst the low sample volume requirement (typically 10-50 µL) is ideally suited for use in paediatric practice and in the elderly population. 
 The reduced storage and shipping requirements allow patients to send their samples via the post, which could streamline the process of transporting samples to the laboratory and improve 
efficiency.
 However, analysts face many challenges with paper-based methods; concerns over volumetric inaccuracy, variability in spot sizes, analyte stability and reproducibility of measurements in sub-
punches, have prohibited the wider use of DBS sampling techniques. Volumetric microsampling devices are able to accurately collect a fixed amount of samples, and because sub-punching is not 
required, it overcomes many drawbacks associated with filter paper collection method.
Assay Characteristics
Effects of Haematocrit (Hct) 
displacement on 25OHD3 concentrations
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 Linearity from 0-125 nmol/L (Typical r2 value ≤ 0.98)
 Lower limit of quantification:  wDBS      1.6 nmol/L,      
spDBS      2.5 nmol/L, Mitra® VAMS      1.5 nmol/L.
Intra-assay precision
Assay recovery
Sample extraction procedure Whole blood K3EDTA samples
from 157 patients were
selected at random, following
routine analysis.
 10 µL of blood was pipetted
into Whatman® 903 Protein
saver cards or sampled using
Mitra® VAMS (10 µL fixed
volume: product number
10006), then left to dry for 18
hours at room temperature
prior to storage at -20°.
 Prior to analysis, DBS samples
were extracted by 1) cutting
the whole spot (wDBS), or by
2) making two 3 mm sub-
punches (spDBS).
wDBS SpDBS VAMS
Mean 25OHD3 nmol/L (%CV) (n = 10)
1 7.5 (16.1) 7.6 (13.6) 7.3 (8.2)
2 23.4 (8.9) 23.2 (9.0) 20.5 (6.7)
3 43.6 (9.1) 45.0 (12.0) 40.3 (6.4)
4 64.2 (6.5) 71.1 (9.8) 59.5 (7.7)
wDBS SpDBS VAMS
Mean 25OHD3 nmol/L (%CV) (n = 6)
Low QC 10.6 (16.6) 12.2 (15.1) 10.9 (7.4)
Medium QC 57.7 (6.9) 62.7 (7.5) 64.8 (7.1)
High QC 82.0 (3.6) 93.3 (8.3) 91.3 (7.0)
Expected 
25OHD3
nmol/L
Mean recovery (%)
wDBS SpDBS VAMS
8.5 102.4 110.2 98.4
21.0 90.0 108.6 104.0
37.5 93.3 97.1 101.7
62.5 89.2 96.7 100.7
87.5 90.3 104.6 95.4
106.3 91.8 102.5 99.6
Overall 
average 
(range)
92.8 
(78.9-
114.1)
103.3 
(88.3-
120)
100.0 
(93.4-
114.1)
Inter-assay precision
 The plasma layer was taken off
in steps until completely
removed.
 Decrease in [25OHD3] were
proportional to the decrease in
plasma volume.
 This shows 25OHD3 in blood is
present primarily in the fluid
compartment, the intracellular
space contained <1.7% of total
25OHD3.
1) Removal of plasma volume
2) Addition of packed cells
 Fig a)-c) Raw 25OHD3 values
produced from DBS and VAMS
(n=97) were correlated with
plasma concentration, but showed
an average negative bias of -39.3%.
1) Whole spot (wDBS)
2) 2x 3mm sub-punches (spDBS)
Vitamin D status
definitions
Plasma 
(no. of cases, 
% in cohort)
PEVwDBS
(n, %)
PEVspDBS
(n, %)
PEVVAMS
(n, %)
<30 nmol/L, 
Deficiency
27 (38.6%) 20 (10%) 15 (17.1%) 24 (4.3%)
30-50 nmol/L, 
Insufficiency
24 (34.3%) 29 (↑7.1%) 31 (10%) 26 (2.9%)
>50 nmol/L, 
sufficiency
19 (27.1%) 21 (2.9%) 24 (7.1%) 20 (1.4%)
 Following interpretation guidelines from the
IOM, we classified the vitamin D status in
our patient cohort (n = 70).
 Using PEVs resulted in an small
underestimation of individuals with
deficiency status.
 Between the three microsampling
techniques, results produced from VAMS
were most representative of plasma.
 VAMS demonstrated benefits over the conventional paper-based
method; the consistency in sampling volume, ease of use without the
need for sub punches, and preservation of sample constituency.
 Our study provides validation of microsampling methodologies for
measurement of 25OHD3 and interpretation of vitamin D status.
 VAMS produced more precise measurements of 25OHD3, and the
most accurate reflection of vitamin D status compared to wDBS and
spDBS.
 Although the recovery of the analyte remains Hct-dependent, the
use of an empirically-derived model to transform DBS values into
clinically-relevant equivalency improves the interpretability of
results.
3) Mitra VAMS
 Fig d)-e) Transforming raw DBS values
into a clinically-relevant PEVs (n=70).
Analysis of concordance correlation
coefficient (CCC) and correctional
bias (Cb) showed good agreement
with plasma concentrations.
 Fig d)-e) Bland-Altman plots
showed the assay bias was
negatively associated with the
increase in Hct levels.
 Mitra VAMS showed the least
deviation across the Hct range.
 When plasma-free packed cells
were added to a whole blood
sample until full saturation,
[25OHD3] decreases as Hct level
increased.
 Despite the constant plasma
volume in the sample, the
increasing level of Hct prevented
the uptake of 25OHD3 into the
microsampling devices.
 Findings from the above studies indicated the concentration of
25OHD3 in whole blood is dependent upon the level of Hct
present, and that measurements using microsampling devices
must be corrected for the level of Hct.
 A 209-day stability plot showing percentage change of 
25OHD3 concentration from day one in samples 
collected by wDBS and VAMS stored at -20°C.
 m/z transitions:
25OHD3 607>298
25OHD3-[
2H6] 613>298 (IS)
Stability in storage
